产品详情
产品名称MelanA Rabbit mAb
克隆号SC56-02
来源种属Recombinant Rabbit
克隆性Monoclonal antibody
纯化ProA affinity purified
应用WB, IHC, FC, ICC/IF
种属反应性Human
免疫原描述recombinant protein
标记Unconjugated
别名Antigen LB39 AA antibody Antigen LB39-AA antibody Antigen SK29 AA antibody Antigen SK29-AA antibody MAR1_HUMAN antibody MART 1 antibody MART-1 antibody MART1 antibody Melan A antibody Melan A protein antibody Melanoma antigen recognized by T cells 1 antibody Melanoma antigen recognized by T-cells 1 antibody MLAN A antibody MLANA antibody OTTHUMP00000021036 antibody OTTHUMP00000021037 antibody OTTHUMP00000021038 antibody Protein Melan-A antibody
数据库入口号Swiss-Prot#:Q16655
Uniprot
Q16655
计算分子量20 kDa
配方1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
保存Store at -20˚C
应用详情
WB: 1:1,000-1:2,000
IHC: 1:50-1:200
ICC/IF: 1:50-1:200
FC: 1:50-1:100
Western blot analysis of MelanA on different lysates using anti-MelanA antibody at 1/1,000 dilution. Positive control: Lane 1: Melanoma Lane 2: B16-F1
Flow cytometric analysis of B16-F1 cells with MelanA antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the seconda antibody
Melanoma-associated antigens recognized by cytotoxic T lymphocytes (CTL) have been grouped into three categories: melanocyte differentiation antigens, cancer/testis-specific antigens and mutated or aberrantly expressed antigens. Many of these antigens consist of peptides that are presented to T cells by HLA molecules; they represent potential targets for cancer immunotherapy. Melan-A (also designated MART-1) is a melanocyte differentiation antigen that is specific to melanomas, melanocyte cell lines and retina. Melan-A peptide is recognized by most HLA-A2-restricted tumor-specific tumor-infiltrating lymphocytes in patients with melanoma. Antimelanoma cytotoxic T lymphocytes can be generated with a Melan-A peptide, implicating Melan-A as a potential candidate for antigen-specific immunotherapy in melanoma patients.
如果您使用该产品48961发表了文章，请通知我们，让我们可以引用您的文献。
Yes
